Maze Therapeutics (NasdaqGM:MAZE) Update / Briefing September 11, 2025 08:30 AM ET Company ParticipantsAmy Bachrodt - SVP - FinanceJason Coloma - CEO & DirectorHarold Bernstein - President - Research & Development and Chief Medical OfficerAnupam Rama - Executive Director - Biotechnology Equity ResearchJoseph Schwartz - Senior MD - Rare DiseasesRy Forseth - Vice PresidentLaura Chico - MD - Equity ResearchJulian Harrison - Managing DirectorConference Call ParticipantsTyler Van Buren - MD - Senior Biotech Equi ...